Plain-English translation of NCT06406569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether stroke patients can use advanced robotic devices at home to help recover arm and hand function after a stroke. Instead of going to a hospital or clinic for rehabilitation, you would take home three different robotic devices—called H-MAN, ReHandyBot, and MyoPanda—and use them for 6 weeks under supervision from a family member or caregiver.
Studies have shown that robotic-assisted therapy works well for stroke recovery, but it has only been tested in hospitals and clinics so far. This trial exists to find out if the same technology can work safely and effectively in patients' homes, which could make rehabilitation more convenient and accessible.
You would first visit the clinic to learn how to use the three robotic devices with help from a therapist. Then you would take the devices home for 6 weeks of self-directed practice, using two devices at a time while your caregiver supervises. The MyoPanda device stays for all 6 weeks, while the H-MAN and ReHandyBot each rotate in for 3-week periods. Researchers will track your progress and assess whether the devices are safe, effective, and feasible to use at home.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Singapore